Notes in PHARM Liver

To Subscribe, use this Key

Status	Last Update	Fields
Published	05/12/2024	What drugs should be avoided/dose adjusted in decompensated advanced liver dz?
Published	05/12/2024	ASCITES: mainstay of therapy?
Published	05/12/2024	MOA of Propranolol for liver dz?
Published	05/12/2024	Spontaneous bacterial peritonitis (SBP): tx?
Published	05/12/2024	Rifampin MOA
Published	05/12/2024	CIs of Glecapravir/Pibrentasvir?
Published	05/12/2024	Review: where are B1, B2, and B3 receptors acting?
Published	05/12/2024	Esophageal varices: next steps after initial tx?
Published	05/12/2024	CI of propranolol
Published	05/12/2024	Hepatic encephalopathy: 1st line tx? what is added if not effective?
Published	05/12/2024	MOA of Glecapravir? Pibrentasvir?
Published	05/12/2024	Sofosbuvir/Velpatasvir (Epclusa): ADRs
Published	05/12/2024	Esophageal varices: 1st line tx?
Published	05/12/2024	Indications for propranolol in liver dz?
Published	05/12/2024	Spontaneous bacterial peritonitis (SBP): recommendation for prophylaxis?
Published	05/12/2024	Tx of HCV for any genotype & how long?
Published	05/12/2024	Sofosbuvir/Velpatasvir (Epclusa): MOA
Published	05/12/2024	ASCITES: what is used to minimize discomfort & prevent SBP?
Published	05/12/2024	MOA of octreotide?
Published	05/12/2024	ADRs of propranolol
Published	05/12/2024	ADRs of Glecapravir/Pibrentasvir?
Published	05/12/2024	Which HCV drug can be used in advanced liver dz?
Published	05/12/2024	1st line tx for portal htn?
Published	05/12/2024	Lactulose MOA
Status	Last Update	Fields